Yasmin Arafah, MD
Hematology & Oncology · Indianapolis, INNPI 1174000707
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $876 of the $1,342 with a category attached, or 65.3%. It is spread thinly across 9 manufacturers, the largest accounting for just 23.8%. Reporting peaked in 2023 at $584 and has fallen 84.5% since, to $90 in 2025. That places this record below the midpoint for hematology & oncology clinicians in IN, where the typical reported total is $3,829.
Across 15 payments — averaging $89.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$319
- Amgen$299
- E.r. Squibb & Sons, L.L.C.$184
- Genentech USA, Inc.$136
- AbbVie$111
- Exelixis Inc.$100
- plus $192 from 3 others
What the payments were for
- Food & beverage$87665%
- Education$46635%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 3 | $319 |
| Amgen | 3 | $299 |
| E.r. Squibb & Sons, L.L.C. | 2 | $184 |
| Genentech USA, Inc. | 1 | $136 |
| AbbVie | 1 | $111 |
| Exelixis Inc. | 1 | $100 |
| GSK | 2 | $90 |
| Seagen Inc. | 1 | $78 |
| Bristol Myers Squibb | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,342 in reported general payments places this provider in the 30th percentile of 224 hematology & oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Indianapolis
- Richard GaynorIndianapolis$3.7M
- Ruemu BirhirayIndianapolis$3.1M
- Anand TandraIndianapolis$280K
- Attaya SuvannasankhaIndianapolis$253K
- Michael DuganIndianapolis$236K
- Daniel MiltonIndianapolis$231K
- Amro ElshouryIndianapolis$212K
- Brian MulherinIndianapolis$175K
- Muhammad Sarfraz NawazIndianapolis$172K
- John EdwardsIndianapolis$169K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.